aldosterone has been researched along with tamoxifen in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Ambus, U; Bruynseels, J; Clark, RM; Crump, M; De Coster, R; Goss, PE; Tye, LM; Wadden, NA; Walde, D; Weizel, HA | 1 |
| Kimura, M; Nomura, Y; Ohashi, Y; Takashima, S; Toge, T; Tominaga, T | 1 |
| Chorazyczewski, J; Davis, M; Ding, Q; Feldman, RD; Gros, R; Liu, B; Pickering, JG; Shaikh, R | 1 |
| Girondo, MA; Goodman, CR; Hooke, JA; Hyslop, T; Kovatich, AJ; Liu, C; Mitchell, EP; Peck, AR; Rui, H; Sato, T; Shriver, CD; Yanac, AF; Yang, N | 1 |
| Bayliss, AL; Evans, NJ; Evans, PD; Reale, V | 1 |
| Gyarmati, G; Hansell, P; Hao, CM; Hu, C; Kohan, DE; Lakshmipathi, J; Peti-Peterdi, J; Stuart, D | 1 |
2 trial(s) available for aldosterone and tamoxifen
| Article | Year |
|---|---|
Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Topics: Aged; Aged, 80 and over; Aldosterone; Androgens; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles | 1995 |
[A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
Topics: Aged; Aldosterone; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Fadrozole; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Tamoxifen | 2000 |
7 other study(ies) available for aldosterone and tamoxifen
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.
Topics: Aldosterone; Animals; Cells, Cultured; Eplerenone; Estradiol; Estrogen Receptor alpha; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myosin Light Chains; Phosphorylation; Rats; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Receptors, Mineralocorticoid; Signal Transduction; Spironolactone; Tamoxifen; Vasoconstriction | 2011 |
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
Topics: Aldosterone; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Hyaluronan Receptors; Keratin-5; MCF-7 Cells; Mice; Mice, Nude; Mineralocorticoids; Neoplasm Recurrence, Local; Neoplasm Transplantation; Progestins; Prognosis; Prolactin; Proto-Oncogene Proteins c-bcl-6; Receptors, Progesterone; RNA Interference; RNA, Small Interfering; Tamoxifen; Transplantation, Heterologous; Up-Regulation | 2016 |
Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18).
Topics: Adenylyl Cyclases; Aldosterone; Animals; Cell Line; Colforsin; Cyclic AMP; Embryo, Mammalian; Estradiol; Fulvestrant; Hippocampus; MAP Kinase Signaling System; Mice; Nitriles; Phenols; Pyrazoles; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Tamoxifen | 2016 |
Renomedullary Interstitial Cell Endothelin A Receptors Regulate BP and Renal Function.
Topics: Aldosterone; Animals; Arginine Vasopressin; Blood Pressure; Calcium; Diuresis; Endothelin-1; Epithelial Sodium Channels; Female; Genotype; Glomerular Filtration Rate; Hyaluronic Acid; Kidney Medulla; Male; Mice; Mice, Knockout; Models, Animal; Natriuresis; Nitrates; Nitrites; Potassium; Receptor, Endothelin A; RNA, Messenger; Selective Estrogen Receptor Modulators; Sodium; Sodium Chloride, Dietary; Tamoxifen; Water | 2020 |